Literature DB >> 33652807

A Pilot Study Comparing the Effects of Consuming 100% Orange Juice or Sucrose-Sweetened Beverage on Risk Factors for Cardiometabolic Disease in Women.

Candice Allister Price1, Valentina Medici2, Marinelle V Nunez3, Vivien Lee1, Desiree M Sigala1, Yanet Benyam1, Nancy L Keim3,4, Ashley E Mason5, Shin-Yu Chen3, Mariana Parenti3, Carolyn Slupsky3, Elissa S Epel6, Peter J Havel1,3, Kimber L Stanhope1,7.   

Abstract

Overconsumption of sugar-sweetened beverages increases risk factors associated with cardiometabolic disease, in part due to hepatic fructose overload. However, it is not clear whether consumption of beverages containing fructose as naturally occurring sugar produces equivalent metabolic dysregulation as beverages containing added sugars. We compared the effects of consuming naturally-sweetened orange juice (OJ) or sucrose-sweetened beverages (sucrose-SB) for two weeks on risk factors for cardiometabolic disease. Healthy, overweight women (n = 20) were assigned to consume either 3 servings of 100% orange juice or sucrose-SB/day. We conducted 16-hour serial blood collections and 3-h oral glucose tolerance tests during a 30-h inpatient visit at baseline and after the 2-week diet intervention. The 16-h area under the curve (AUC) for uric acid increased in subjects consuming sucrose-SB compared with subjects consuming OJ. Unlike sucrose-SB, OJ did not significantly increase fasting or postprandial lipoproteins. Consumption of both beverages resulted in reductions in the Matsuda insulin sensitivity index (OJ: -0.40 ± 0.18, p = 0.04 within group; sucrose-SB: -1.0 ± 0.38, p = 0.006 within group; p = 0.53 between groups). Findings from this pilot study suggest that consumption of OJ at levels above the current dietary guidelines for sugar intake does not increase plasma uric acid concentrations compared with sucrose-SB, but appears to lead to comparable decreases of insulin sensitivity.

Entities:  

Keywords:  fruit juice; insulin sensitivity; lipids; sugar-sweetened beverage; uric acid

Mesh:

Substances:

Year:  2021        PMID: 33652807      PMCID: PMC7996959          DOI: 10.3390/nu13030760

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   6.706


  62 in total

1.  Stimulation of human purine synthesis de novo by fructose infusion.

Authors:  K O Raivio; 7 A Becker; L J Meyer; M L Greene; G Nuki; J E Seegmiller
Journal:  Metabolism       Date:  1975-07       Impact factor: 8.694

2.  High serum uric acid as a novel risk factor for type 2 diabetes.

Authors:  Abbas Dehghan; Mandy van Hoek; Eric J G Sijbrands; Albert Hofman; Jacqueline C M Witteman
Journal:  Diabetes Care       Date:  2007-10-31       Impact factor: 19.112

3.  Ethanol metabolism and production of free acetate in the human liver.

Authors:  F LUNDQUIST; N TYGSTRUP; K WINKLER; K MELLEMGAARD; S MUNCK-PETERSEN
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

4.  Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials.

Authors:  Stephen P Juraschek; Edgar R Miller; Allan C Gelber
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-09       Impact factor: 4.794

5.  Effects of cranberry juice consumption on vascular function in patients with coronary artery disease.

Authors:  Mustali M Dohadwala; Monika Holbrook; Naomi M Hamburg; Sherene M Shenouda; William B Chung; Megan Titas; Matthew A Kluge; Na Wang; Joseph Palmisano; Paul E Milbury; Jeffrey B Blumberg; Joseph A Vita
Journal:  Am J Clin Nutr       Date:  2011-03-16       Impact factor: 7.045

6.  alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population.

Authors:  Walter E Gall; Kirk Beebe; Kay A Lawton; Klaus-Peter Adam; Matthew W Mitchell; Pamela J Nakhle; John A Ryals; Michael V Milburn; Monica Nannipieri; Stefania Camastra; Andrea Natali; Ele Ferrannini
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

7.  Value of ethyl glucuronide in plasma as a biomarker for recent alcohol consumption in the emergency room.

Authors:  Tim Neumann; Anders Helander; Helen Dahl; Tilly Holzmann; Bruno Neuner; Edith Weiss-Gerlach; Christian Müller; Claudia Spies
Journal:  Alcohol Alcohol       Date:  2008-05-25       Impact factor: 2.826

8.  100% orange juice consumption is associated with better diet quality, improved nutrient adequacy, decreased risk for obesity, and improved biomarkers of health in adults: National Health and Nutrition Examination Survey, 2003-2006.

Authors:  Carol E O'Neil; Theresa A Nicklas; Gail C Rampersaud; Victor L Fulgoni
Journal:  Nutr J       Date:  2012-12-12       Impact factor: 3.271

9.  Orange juice and hesperetin supplementation to hyperuricemic rats alter oxidative stress markers and xanthine oxidoreductase activity.

Authors:  Fatemeh Haidari; Seid Ali Keshavarz; Mohammad Reza Rashidi; Majid Mohammad Shahi
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

10.  Chemical Evidence for Potent Xanthine Oxidase Inhibitory Activity of Ethyl Acetate Extract of Citrus aurantium L. Dried Immature Fruits.

Authors:  Kun Liu; Wei Wang; Bing-Hua Guo; Hua Gao; Yang Liu; Xiao-Hong Liu; Hui-Li Yao; Kun Cheng
Journal:  Molecules       Date:  2016-03-02       Impact factor: 4.411

View more
  2 in total

Review 1.  Gout and Diet: A Comprehensive Review of Mechanisms and Management.

Authors:  Yingling Zhang; Simin Chen; Man Yuan; Yu Xu; Hongxi Xu
Journal:  Nutrients       Date:  2022-08-26       Impact factor: 6.706

2.  Consuming Sucrose- or HFCS-sweetened Beverages Increases Hepatic Lipid and Decreases Insulin Sensitivity in Adults.

Authors:  Desiree M Sigala; Bettina Hieronimus; Valentina Medici; Vivien Lee; Marinelle V Nunez; Andrew A Bremer; Chad L Cox; Candice A Price; Yanet Benyam; Abhijit J Chaudhari; Yasser Abdelhafez; John P McGahan; Michael I Goran; Claude B Sirlin; Giovanni Pacini; Andrea Tura; Nancy L Keim; Peter J Havel; Kimber L Stanhope
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.